CCNA1 | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 14 of 14 results for "CCNA1"
i
  1. CCNA1_RAT UniProt:Swiss-Prot

    ID: Q6AY13

    Description: Cyclin-A1

  2. CCNA1_XENLA UniProt:Swiss-Prot

    ID: P18606

    Description: Cyclin-A1

  3. Expression data from 22 human myotubes ArrayExpress

    ID: E-GEOD-44874

    Description: deficiency FHL1).cDNA microarray data showed that cyclin A1 levels are specifically elevated in FSHD vs. other muscular disorders such as CAV3, DYSF, FHL1 and healthy control. Data could be confirmed with RT-PCR and Western blot analysis showing up-regulated levels of cyclin A1 also on the protein level. Comparison of g...

  4. Expression data from 22 human myotubes BioProject

    ID: PRJNA192214

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: deficiency FHL1).cDNA microarray data showed that cyclin A1 levels are specifically elevated in FSHD vs. other muscular disorders such as CAV3, DYSF, FHL1 and healthy control. Data could be confirmed with RT-PCR and Western blot analysis showing up-regulated levels of cyclin A1 also on the protein level. Comparison of g...
  5. Transcription profiling of human Hela CD4+ cells transfected with epitope tagged eTat or parental vector to identify therapeutic targets for HIV-1 inf... ArrayExpress

    ID: E-GEOD-6431

    Description: t1/2 binding protein, an HIV Rev binding protein, cyclin A, and PPGB, a cathepsin that binds NA, are important for viral replication following induction from latency and de novo infection of PBMCs. CONCLUSION: Based on exhaustive and stringent data analysis, we have compiled a list of gene products that may serve as potential therapeutic targets for the inhibition of HIV-1 replication. Several genes have been established as important for HIV-1 infection and replication, including Pou2AF1 (OBF-1), complement factor H related 3, CD4 receptor, ICAM-1, NA, and cyclin A1. There were also several genes whose role in relation to HIV-1 infection have not been established and may also be novel and efficacious therapeutic targets and thus necessitate further study. Importantly, targeting certain cellular protein kinases, receptors, membrane proteins, and/or cytokines/chemokines may result in adverse effects. If there is the presence of two or more proteins with similar functions, where only one prote...

  6. CCA11_ARATH UniProt:Swiss-Prot

    ID: Q9C6Y3

    Description: Cyclin-A1-1

  7. CCNA1_CAEEL UniProt:Swiss-Prot

    ID: P34638

    Description: G2/mitotic-specific cyclin-A1

  8. CCA12_ARATH UniProt:Swiss-Prot

    ID: Q9FVX0

    Description: Cyclin-A1-2 In tam; alters male meiosis progression

  9. CCNA1_CARAU UniProt:Swiss-Prot

    ID: Q92161

    Description: Cyclin-A1

  10. Expression data from 22 human myotubes OmicsDI

    ID: E-GEOD-44874

    Date Released: 08-21-2013

    Description: deficiency FHL1).cDNA microarray data showed that cyclin A1 levels are specifically elevated in FSHD vs. other muscular disorders such as CAV3, DYSF, FHL1 and healthy control. Data could be confirmed with RT-PCR and Western blot analysis showing up-regulated levels of cyclin A1 also on the protein level. Comparison of g...

  11. Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation BioProject

    ID: PRJNA178411

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: on of several genes regulated by β-catenin (e.g. CCNA1, CCNE2, WISP1, ID4, SFN, ME1) that may help to explain altered tumor growth and metastasis. In conclusion, these results provide the first evidence for TSPAN12 playing a role in supporting primary tumor growth and suppressing metastasis. TSPAN12 appears to function by stabilizing FZD4-LRP5 association, in support of canonical Wnt-pathway signaling, leading to enhanced β-catenin expression and function. Overall design: 4 samples = 2 Control + 2 TSPAN12KD...
  12. cAMP Ca2+ NFAT signalling in RPTEC control vs. CAA BioProject

    ID: PRJNA96707

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: DK5, IL2, PLN, SRF, GCG, SGK, JUNB, BDNF, S100A6, CCNA1, MIF, HK2, SST and EGR2 by CAA was observed in two independent experiments. From the AP-1 family expression of junD and fosB were not altered. Overexpression by CAA of CREB and DDIT3 were only observed in one of two experiments. JUND, FOSB, FOSL1, CREM and CREBBP expression was not influenced in reproducible manner, as well as all members of the NFAT-family. In the Ca2+/NFAT-Arrays, PPP3CB, VAV3, NFATC1, IL8, IL6, FASLG, IL3, IFNB1, FOS, BCL2, EGR3, CD3G, HRAS, EP300, IL4, CALM3, RELA, EGR2, NPPB, IFNG, NFATC4, KPNA5, CAMK2BNFKB2 , VEGF, IL8RA, IL2,GATA4, MEF2A, PTPRC, ICOS, NFKBIE, CDKN1A, CSNK2B, ACTB, MEF2B and JUNB mRNA´s were repeatedly reduced by CAA exposure. The only gene with upregulation in both experiments was found to be IFN-alpha. Thus CAA exposure f...
  13. Transcription profiling of human Hela CD4+ cells transfected with epitope tagged eTat or parental vector to identify therapeutic targets for HIV-1 inf... OmicsDI

    ID: E-GEOD-6431

    Date Released: 03-27-2012

    Description: t1/2 binding protein, an HIV Rev binding protein, cyclin A, and PPGB, a cathepsin that binds NA, are important for viral replication following induction from latency and de novo infection of PBMCs. CONCLUSION: Based on exhaustive and stringent data analysis, we have compiled a list of gene products that may serve as potential therapeutic targets for the inhibition of HIV-1 replication. Several genes have been established as important for HIV-1 infection and replication, including Pou2AF1 (OBF-1), complement factor H related 3, CD4 receptor, ICAM-1, NA, and cyclin A1. There were also several genes whose role in relation to HIV-1 infection have not been established and may also be novel and efficacious therapeutic targets and thus necessitate further study. Importantly, targeting certain cellular protein kinases, receptors, membrane proteins, and/or cytokines/chemokines may result in adverse effects. If there is the presence of two or more proteins with similar functions, where only one prote...

  14. Cytoscan HD arrays data for Nodal marginal zone lymphoma (NMZL) BioProject

    ID: PRJNA281882

    Keywords: Variation

    Access Type: download

    dataset.description: , the cases investigated: i) lacked CD5, CD10 and cyclin D1 expression, 7q deletion, t(11;14), t(14;18), t(11;18) and t(1;14) translocations; and ii) recurrently harbored +3 (14%), +12 (14%) and preferential usage of the IGHV4-34 gene (17%). WES (HiSeq 2500, Illumina; mean coverage per sample: 38x-114x) and high resolution SNP array (Cytoscan HD, Affymetrix) of tumor/normal DNA pairs from 18 discovery NMZL identified 557 non-synonymous somatic mutations (average: 30.8/case) affecting 504 genes and 51 copy number abnormalities (CNA) (average: 3.2/case). To further characterize mutation recurrence, the 504 discovered genes were investigated in an independent validation panel of 17 NMZL by targeted sequencing of tumor/normal DNA pairs (MiSeq; target region: 1.6 Mb; mean coverage per sample: 171x-386x). The 17 validation NMZL w...

Displaying 14 of 14 results for "CCNA1"